MedTrace Logo

Trial of 2% Chlorhexidine Bathing on Nosocomial Infections in the Surgical Intensive Care Unit

NCT01640925 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 350

Last updated 2018-04-27

Study results available
· View outcomes & findings →

Summary

This prospective, randomized, controlled trial will compare the incidence of nosocomial infections (composite of primary bloodstream infections, catheter-associated urinary tract infections, ventilator-associated pneumonia, and surgical site infections) that occur in intensive care unit (ICU) patients bathed with 2% chlorhexidine solution versus patients who receive standard bathing (soap and water or non-medicated cloths).

Conditions

  • Cross Infection
  • Pneumonia, Ventilator-associated
  • Catheter-related Infections
  • Infection Due to Indwelling Urinary Catheter
  • Surgical Wound Infection

Interventions

DRUG

Chlorhexidine gluconate

Chlorhexidine gluconate 2% solution applied topically for full body bathing once every 48 hours

OTHER

Standard bathing

The patient will be bathed using standard bathing (non-medicated cloths or soap and water) daily.

Sponsors & Collaborators

  • Texas Southern University

    collaborator OTHER

  • The Methodist Hospital Research Institute

    collaborator OTHER

  • Joshua Swan

    lead OTHER

Principal Investigators

  • Joshua T Swan, Pharm.D. · The Methodist Hospital, Texas Southern University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2013-05-31
Completion
2014-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01640925 on ClinicalTrials.gov